Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 18199767)

1.

Antiapoptotic and trophic effects of dominant-negative forms of dual leucine zipper kinase in dopamine neurons of the substantia nigra in vivo.

Chen X, Rzhetskaya M, Kareva T, Bland R, During MJ, Tank AW, Kholodilov N, Burke RE.

J Neurosci. 2008 Jan 16;28(3):672-80. doi: 10.1523/JNEUROSCI.2132-07.2008.

2.

Dual leucine zipper kinase inhibitors: potential treatments for neurodegenerative diseases.

Abdel-Magid AF.

ACS Med Chem Lett. 2014 Sep 9;6(1):11-2. doi: 10.1021/ml500347s. eCollection 2015 Jan 8. No abstract available.

PMID:
25589918
3.

ZPK/DLK and MKK4 form the critical gateway to axotomy-induced motoneuron death in neonates.

Itoh T, Horiuchi M, Ikeda RH Jr, Xu J, Bannerman P, Pleasure D, Penninger JM, Tournier C, Itoh A.

J Neurosci. 2014 Aug 6;34(32):10729-42. doi: 10.1523/JNEUROSCI.0539-14.2014.

4.

The systemic administration of oleoylethanolamide exerts neuroprotection of the nigrostriatal system in experimental Parkinsonism.

Gonzalez-Aparicio R, Blanco E, Serrano A, Pavon FJ, Parsons LH, Maldonado R, Robledo P, Fernandez-Espejo E, de Fonseca FR.

Int J Neuropsychopharmacol. 2014 Mar;17(3):455-68. doi: 10.1017/S1461145713001259. Epub 2013 Oct 29.

PMID:
24169105
5.

Mapping and kinetics of microglia/neuron cell-to-cell contacts in the 6-OHDA murine model of Parkinson's disease.

Virgone-Carlotta A, Uhlrich J, Akram MN, Ressnikoff D, Chrétien F, Domenget C, Gherardi R, Despars G, Jurdic P, Honnorat J, Nataf S, Touret M.

Glia. 2013 Oct;61(10):1645-58. doi: 10.1002/glia.22546. Epub 2013 Jul 25.

PMID:
23893349
6.

Acetylcholinesterase deficiency decreases apoptosis in dopaminergic neurons in the neurotoxin model of Parkinson's disease.

Zhang X, Lu L, Liu S, Ye W, Wu J, Zhang X.

Int J Biochem Cell Biol. 2013 Feb;45(2):265-72. doi: 10.1016/j.biocel.2012.11.015. Epub 2012 Nov 29.

PMID:
23201480
7.

Neurotrophic effects of serum- and glucocorticoid-inducible kinase on adult murine mesencephalic dopamine neurons.

Chen X, Tagliaferro P, Kareva T, Yarygina O, Kholodilov N, Burke RE.

J Neurosci. 2012 Aug 15;32(33):11299-308. doi: 10.1523/JNEUROSCI.5910-11.2012.

8.

Activation of transcription factor MEF2D by bis(3)-cognitin protects dopaminergic neurons and ameliorates Parkinsonian motor defects.

Yao L, Li W, She H, Dou J, Jia L, He Y, Yang Q, Zhu J, Cápiro NL, Walker DI, Pennell KD, Pang Y, Liu Y, Han Y, Mao Z.

J Biol Chem. 2012 Oct 5;287(41):34246-55. doi: 10.1074/jbc.M112.367540. Epub 2012 Aug 13.

9.

DLK induces developmental neuronal degeneration via selective regulation of proapoptotic JNK activity.

Ghosh AS, Wang B, Pozniak CD, Chen M, Watts RJ, Lewcock JW.

J Cell Biol. 2011 Sep 5;194(5):751-64. doi: 10.1083/jcb.201103153.

10.

Effects of chronic, systemic treatment with the dopamine receptor agonist R-apomorphine in partially lesioned rat model of Parkinson's disease: an electrophysiological study of substantia nigra dopamine neurons.

Gui ZH, Liu J, Wang Y, Ali U, Wang T, Chen L.

Chin J Physiol. 2011 Apr 30;54(2):96-104. Erratum in: Chin J Physiol. 2011 Jun 30;54(3):203.

PMID:
21789890
11.

ZPK/DLK, a mitogen-activated protein kinase kinase kinase, is a critical mediator of programmed cell death of motoneurons.

Itoh A, Horiuchi M, Wakayama K, Xu J, Bannerman P, Pleasure D, Itoh T.

J Neurosci. 2011 May 18;31(20):7223-8. doi: 10.1523/JNEUROSCI.5947-10.2011.

12.
13.

Akt suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy.

Cheng HC, Kim SR, Oo TF, Kareva T, Yarygina O, Rzhetskaya M, Wang C, During M, Talloczy Z, Tanaka K, Komatsu M, Kobayashi K, Okano H, Kholodilov N, Burke RE.

J Neurosci. 2011 Feb 9;31(6):2125-35. doi: 10.1523/JNEUROSCI.5519-10.2011.

14.

Peroxiredoxin-2 protects against 6-hydroxydopamine-induced dopaminergic neurodegeneration via attenuation of the apoptosis signal-regulating kinase (ASK1) signaling cascade.

Hu X, Weng Z, Chu CT, Zhang L, Cao G, Gao Y, Signore A, Zhu J, Hastings T, Greenamyre JT, Chen J.

J Neurosci. 2011 Jan 5;31(1):247-61. doi: 10.1523/JNEUROSCI.4589-10.2011.

15.

Mkp1 is a c-Jun target gene that antagonizes JNK-dependent apoptosis in sympathetic neurons.

Kristiansen M, Hughes R, Patel P, Jacques TS, Clark AR, Ham J.

J Neurosci. 2010 Aug 11;30(32):10820-32. doi: 10.1523/JNEUROSCI.2824-10.2010.

17.

Rapamycin protects against neuron death in in vitro and in vivo models of Parkinson's disease.

Malagelada C, Jin ZH, Jackson-Lewis V, Przedborski S, Greene LA.

J Neurosci. 2010 Jan 20;30(3):1166-75. doi: 10.1523/JNEUROSCI.3944-09.2010.

18.

Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson's disease.

Doo AR, Kim ST, Kim SN, Moon W, Yin CS, Chae Y, Park HK, Lee H, Park HJ.

Neurol Res. 2010 Feb;32 Suppl 1:88-91. doi: 10.1179/016164109X12537002794282.

PMID:
20034453
19.

Role of dual leucine zipper-bearing kinase (DLK/MUK/ZPK) in axonal growth.

Eto K, Kawauchi T, Osawa M, Tabata H, Nakajima K.

Neurosci Res. 2010 Jan;66(1):37-45. doi: 10.1016/j.neures.2009.09.1708. Epub 2009 Oct 4.

PMID:
19808064
20.

Neuroprotective effect of L-dopa on dopaminergic neurons is comparable to pramipexol in MPTP-treated animal model of Parkinson's disease: a direct comparison study.

Shin JY, Park HJ, Ahn YH, Lee PH.

J Neurochem. 2009 Nov;111(4):1042-50. doi: 10.1111/j.1471-4159.2009.06381.x. Epub 2009 Sep 16.

PMID:
19765187
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk